Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shuster

Showing results (301-310 of 513) with videos related to

Pageof 52
Sort By:
Blood|February 15, 1995
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemiaF M Uckun, H Sather, G Reaman, et al.
The American Journal of Managed Care|December 17, 2016
The effect of EHR-integrated patient-reported outcomes on satisfaction with chronic pain careChristopher A Harle, Nicole M Marlow, Siegfried O F Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
Cancer|September 15, 1982
CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group studyD M Komp, C H Fernandez, J M Falletta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
IL-1 receptor accessory protein is an essential component of the IL-1 receptorE B Cullinan, L Kwee, P Nunes, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group studyM P Sullivan, M Brecher, I Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Localized neuroblastoma treated by surgery: a Pediatric Oncology Group StudyR Nitschke, E I Smith, S Shochat, et al.
Pediatric Transplantation|April 16, 2011
Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication eventsVikas R Dharnidharka, Sushil Gupta, Eihab Al Khasawneh, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1995
Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastomaD Strother, J J Shuster, N McWilliams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group studyR Nitschke, E I Smith, G Altshuler, et al.
Pageof 52

Showing results (301-310 of 513) with videos related to

Sort By:
Pageof 52
Blood|February 15, 1995
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemiaF M Uckun, H Sather, G Reaman, et al.
The American Journal of Managed Care|December 17, 2016
The effect of EHR-integrated patient-reported outcomes on satisfaction with chronic pain careChristopher A Harle, Nicole M Marlow, Siegfried O F Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
Cancer|September 15, 1982
CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group studyD M Komp, C H Fernandez, J M Falletta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
IL-1 receptor accessory protein is an essential component of the IL-1 receptorE B Cullinan, L Kwee, P Nunes, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group studyM P Sullivan, M Brecher, I Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Localized neuroblastoma treated by surgery: a Pediatric Oncology Group StudyR Nitschke, E I Smith, S Shochat, et al.
Pediatric Transplantation|April 16, 2011
Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication eventsVikas R Dharnidharka, Sushil Gupta, Eihab Al Khasawneh, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1995
Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastomaD Strother, J J Shuster, N McWilliams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group studyR Nitschke, E I Smith, G Altshuler, et al.
Pageof 52